Trending
- Illegal imports of Wegovy, Mounjaro surge as overseas direct purchases proliferate
- Over 5200 cases recorded as Democratic Republic of the Congo crosses 100 days since Ebola outbreak declaration
- Psychology says people who check their phone immediately after waking up may be seeking more than notifications – What this everyday habit could reveal about their mindset
- Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
- U.S. Sailors exercise aboard USS Carl Vinson (CVN 70)
- Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?
- What makes a lifestyle vehicle? Why India’s market remains niche beyond the Mahindra Thar
- How well do COVID antivirals actually work? Not as well as we thought
Monday, August 24
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium
By healthylife7